Solicitation of Written Comments on the Maternal Immunizations Working Group's Draft Report and Draft Recommendations for Reducing Patient and Provider Barriers to Maternal Immunizations for Consideration by the National Vaccine Advisory Committee, 16797-16798 [2014-06594]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 58 / Wednesday, March 26, 2014 / Notices
Effective: March 26, 2014.
Meeting date: The meeting will be
held on Wednesday, April 9, 2013
starting at 10:00 a.m. Eastern Daylight
Time (EDT), and ending no later than
12:00 p.m. Eastern Daylight Time (EDT).
The meeting will be conducted
telephonically. Persons wishing to listen
to the proceedings may dial 712–432–
1001 and enter access code 474845614#.
Note this is not a toll-free number.
FOR FURTHER INFORMATION CONTACT:
Daniel S. Dayton, Designated Federal
Officer, c/o The Foundation for the
Commemoration of the World Wars, 701
Pennsylvania Avenue NW., #123,
Washington, DC 20004–2608 202–380–
0725 (note: this is not a toll-free
number).
Written Comments may be submitted
to the Commission and will be made
part of the permanent record of the
Commission. Comments must be
received by 5:00 p.m. Eastern Daylight
Time (EDT), April 2, 2014 and may be
provided by email to daniel.dayton@
dhs.gov.
SUPPLEMENTARY INFORMATION:
and enter access code 474845614#.
Capacity for this call is 1000 callers.
Background
The World War One Centennial
Commission was established by Public
Law 112–272, as a commission to
ensure a suitable observance of the
centennial of World War I, to provide
for the designation of memorials to the
service of members of the United States
Armed Forces in World War I, and for
other purposes. Under this authority,
the Committee will plan, develop, and
execute programs, projects, and
activities to commemorate the
centennial of World War I, encourage
private organizations and State and
local governments to organize and
participate in activities commemorating
the centennial of World War I, facilitate
and coordinate activities throughout the
United States relating to the centennial
of World War I, serve as a clearinghouse
for the collection and dissemination of
information about events and plans for
the centennial of World War I, and
develop recommendations for Congress
and the President for commemorating
the centennial of World War I.
Agenda: Wednesday April 9, 2014
• Introductions and plans for today’s
meeting—Designated Federal Official
• Committee Reports
• Old Business
• New Business
• Public Comments
• Closing comments
Meeting Location: The Committee will
convene its meeting telephonically.
Persons wishing to listen to the
proceedings may dial 712–432–1001
SUMMARY:
sroberts on DSK5SPTVN1PROD with NOTICES
DATES:
VerDate Mar<15>2010
17:43 Mar 25, 2014
Jkt 232001
Dated: March 20, 2014.
Daniel S. Dayton,
Designated Federal Official, World War I
Centennial Commission.
[FR Doc. 2014–06635 Filed 3–25–14; 8:45 am]
BILLING CODE 6820–95–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Written Comments on
the Maternal Immunizations Working
Group’s Draft Report and Draft
Recommendations for Reducing
Patient and Provider Barriers to
Maternal Immunizations for
Consideration by the National Vaccine
Advisory Committee
National Vaccine Program
Office, Office of the Assistant Secretary
for Health, Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
The National Vaccine
Advisory Committee (NVAC) was
established in 1987 to comply with Title
XXI of the Public Health Service Act
(Pub. L. 99–660) (§ 2105) (42 U.S. Code
300aa–5 (PDF–78 KB) ). Its purpose is to
advise and make recommendations to
the Director of the National Vaccine
Program on matters related to program
responsibilities. The Assistant Secretary
for Health (ASH) has been designated by
the Secretary of Health and Human
Services (HHS) as the Director of the
National Vaccine Program. The National
Vaccine Program Office (NVPO) is
located within the Office of the
Assistant Secretary for Health (OASH),
Office of the Secretary, U.S. Department
of Health and Human Services (HHS).
NVPO provides leadership and fosters
collaboration among the various federal
agencies involved in vaccine and
immunization activities. The NVPO also
supports the National Vaccine Advisory
Committee (NVAC). The NVAC advises
and makes recommendations to the
ASH in his capacity as the Director of
National Vaccine Program on matters
related to vaccine program
responsibilities.
In June 2012, the NVAC accepted a
charge from the ASH to review the
current state of maternal immunization
and existing best practices and identify
programmatic barriers to the
implementation of current
recommendations related to maternal
immunization. The NVAC formed the
Maternal Immunizations Working
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
16797
Group in August 2012 to address this
charge.
Through a series of teleconferences,
electronic communications, and public
discussions during NVAC meetings, the
working group developed a number of
draft recommendations for
consideration by the NVAC. The NVAC
draft report details the background and
rationale for each of these
recommendations and provides input
on how the ASH might support HHS
activities in these areas. The draft report
and draft recommendations from the
working group will inform NVAC
deliberations as the NVAC finalizes
their recommendations for transmittal to
the ASH.
NVPO is soliciting public comment
on the draft report and draft
recommendations from a variety of
stakeholders, including the general
public, for consideration by the NVAC
as they develop their final
recommendations to the ASH. It is
anticipated that the draft report and
draft recommendations, as revised with
consideration given to public comment
and stakeholder input, will be presented
to the NVAC for adoption in June 2014
at the quarterly NVAC meeting.
DATES: Comments for consideration by
the NVAC should be received no later
than 5:00 p.m. EDT on April 25, 2014.
ADDRESSES:
(1) The draft report and draft
recommendations are available on the
web at https://www.hhs.gov/nvpo/nvac/
index.html.
(2) Electronic responses are preferred
and may be addressed to:
Jennifer.Gordon@hhs.gov.
(3) Written responses should be
addressed to: National Vaccine Program
Office, U.S. Department of Health and
Human Services, 200 Independence
Avenue SW., Room 733G, Washington,
DC 20201. Attn: HHS Maternal
Immunizations c/o Dr. Jennifer Gordon
FOR FURTHER INFORMATION CONTACT:
Jennifer Gordon, Ph.D., National
Vaccine Program Office, Office of the
Assistant Secretary for Health,
Department of Health and Human
Services; telephone (202) 260–6619; fax
(202) 260–1165; email:
Jennifer.Gordon@hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
Pregnant women and their infants are
at increased risk for serious
complications due to vaccinepreventable diseases. For example,
during the 2009 H1N1 influenza
pandemic, pregnant women accounted
for five percent of all reported H1N1related deaths and were 7.2 times more
E:\FR\FM\26MRN1.SGM
26MRN1
sroberts on DSK5SPTVN1PROD with NOTICES
16798
Federal Register / Vol. 79, No. 58 / Wednesday, March 26, 2014 / Notices
likely to be hospitalized than nonpregnant women. Infants too young to
be vaccinated are also vulnerable to
severe outcomes and death due to
influenza and pertussis disease.
Maternal immunization is an important
strategy to protect both pregnant women
and their young infants from vaccinepreventable disease, and both the
Advisory Committee for Immunization
Practices and the American College of
Obstetricians and Gynecologists
recommend that all pregnant women
receive immunizations against influenza
and pertussis disease during every
pregnancy. However, despite evidence
to support clear health benefits of
maternal immunization for pregnant
women and infant, immunization
coverage in pregnant women remains
low. In addition, many pregnant women
reported that their provider did not
recommend that they receive vaccines,
indicating ongoing missed opportunities
during healthcare interactions.
Therefore, it is critical to understand the
barriers that both prevent pregnant
women from receiving recommended
vaccinations and those that prevent
obstetrical care providers from
recommending and administering
vaccines within their practices. Doing so
will help to advance maternal
immunization efforts and increase
coverage to maximize the number of
pregnant women and young infants that
can benefit from these strategies.
Through their analysis and
discussion, the NVAC identified five
major areas of opportunity:
1. Enhancing communication to
address the safety and effectiveness of
all currently recommended
immunizations during pregnancy;
2. Maximizing obstetric provider
recommendation and administration of
recommended maternal immunizations;
3. Focusing efforts to improve
financing for immunization services
during pregnancy and postpartum;
4. Supporting efforts to increase the
use of electronic health records (EHRs)
and Immunization Information Systems
(IISs) among obstetrical care providers;
and
5. Recognizing and addressing current
vaccine liability law barriers to optimize
investigations and uptake of
recommended and future vaccines
during pregnancy.
Within each area the NVAC report
details key recommendations to
overcoming challenges in these areas.
II. Request for Comment
NVPO, on behalf of the NVAC
Maternal Immunizations Working
Group, requests input on the draft report
and draft recommendations. In addition
VerDate Mar<15>2010
17:43 Mar 25, 2014
Jkt 232001
to general comments on the draft report
and draft recommendations, NVPO is
seeking input on efforts or barriers to
maternal immunizations not
represented in the report where HHS
efforts could advance maternal
immunization efforts. Please limit your
comments to six (6) pages.
III. Potential Responders
HHS invites input from a broad range
of stakeholders including individuals
and organizations that have interests in
maternal immunization efforts and the
role of HHS in advancing those efforts.
Examples of potential responders
include, but are not limited to, the
following:
—general public;
—advocacy groups, non-profit
organizations, and public interest
organizations;
—academics, professional societies, and
healthcare organizations;
—public health officials and
immunization program managers;
—obstetrical care provider groups
including all physician and nonphysician providers that administer
healthcare services to pregnant
women, including pharmacists; and
—representatives from the private
sector.
When responding, please self-identify
with any of the above or other categories
(include all that apply) and your name.
Anonymous submissions will not be
considered. Written submissions should
not exceed six (6) pages. Please do not
send proprietary, commercial, financial,
business, confidential, trade secret, or
personal information.
Dated: March 13, 2014.
Bruce Gellin,
Deputy Assistant Secretary for Health,
Director, National Vaccine Program Office,
Executive Secretary, National Vaccine
Advisory Committee.
[FR Doc. 2014–06594 Filed 3–25–14; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Partnerships To Advance the National
Occupational Research Agenda
(NORA)
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of public meeting.
AGENCY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the following public
meeting, which will be held as a
webinar: ‘‘Partnerships to Advance the
National Occupational Research Agenda
(NORA)’’.
Public Meeting Time and Date: 1
p.m.–2:30 p.m. EDT, April 22, 2014.
Place: Online and teleconference
only, see details below.
Purpose of the Meeting: The National
Occupational Research Agenda (NORA)
has been structured to engage partners
with each other and/or with NIOSH to
advance NORA priorities. The NORA
Liaison Committee continues to be an
opportunity for representatives from
organizations with national scope to
learn about NORA progress and to
suggest possible partnerships based on
their organization’s mission and
contacts. This opportunity is now
structured as a public meeting via the
Internet to attract participation by a
larger number of organizations and to
further enhance the success of NORA.
Some of the types of organizations of
national scope that are especially
encouraged to participate are employers,
unions, trade associations, labor
associations, professional associations,
and foundations. Others are welcome.
This meeting will include:
• Updates from NIOSH leadership on
NORA and on plans for evaluating the
second decade of NORA;
• A discussion of a variety of metrics
NIOSH is considering for measuring its
performance as a research agency;
• Brief written updates from most of
the NORA Sector Councils on their
progress, priorities, and implementation
plans to date, likely including the
NORA Agriculture, Forestry and
Fishing; Construction; Healthcare and
Social Assistance; Manufacturing;
Mining; Oil and Gas Extraction; Public
Safety; Services; Transportation,
Warehousing and Utilities; and
Wholesale and Retail Trade Sector
Councils; and
• Time to ask questions and discuss
partnership opportunities.
Status: The meeting is open to the
public, limited only by the capacities of
the conference call and online system
for sharing slides. Everyone can
participate through the Internet (to see
the slides) and a teleconference call
(capacity 50). Each participant is
requested to register for the free meeting
by sending an email to
noracoordinator@cdc.gov containing the
participant’s name, organization name,
and contact telephone number on the
day of the meeting. Requirements
SUMMARY:
E:\FR\FM\26MRN1.SGM
26MRN1
]]>Agencies
[Federal Register Volume 79, Number 58 (Wednesday, March 26, 2014)]
[Notices]
[Pages 16797-16798]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-06594]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Written Comments on the Maternal Immunizations
Working Group's Draft Report and Draft Recommendations for Reducing
Patient and Provider Barriers to Maternal Immunizations for
Consideration by the National Vaccine Advisory Committee
AGENCY: National Vaccine Program Office, Office of the Assistant
Secretary for Health, Office of the Secretary, Department of Health and
Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Vaccine Advisory Committee (NVAC) was established
in 1987 to comply with Title XXI of the Public Health Service Act (Pub.
L. 99-660) (Sec. 2105) (42 U.S. Code 300aa-5 (PDF-78 KB) ). Its
purpose is to advise and make recommendations to the Director of the
National Vaccine Program on matters related to program
responsibilities. The Assistant Secretary for Health (ASH) has been
designated by the Secretary of Health and Human Services (HHS) as the
Director of the National Vaccine Program. The National Vaccine Program
Office (NVPO) is located within the Office of the Assistant Secretary
for Health (OASH), Office of the Secretary, U.S. Department of Health
and Human Services (HHS). NVPO provides leadership and fosters
collaboration among the various federal agencies involved in vaccine
and immunization activities. The NVPO also supports the National
Vaccine Advisory Committee (NVAC). The NVAC advises and makes
recommendations to the ASH in his capacity as the Director of National
Vaccine Program on matters related to vaccine program responsibilities.
In June 2012, the NVAC accepted a charge from the ASH to review the
current state of maternal immunization and existing best practices and
identify programmatic barriers to the implementation of current
recommendations related to maternal immunization. The NVAC formed the
Maternal Immunizations Working Group in August 2012 to address this
charge.
Through a series of teleconferences, electronic communications, and
public discussions during NVAC meetings, the working group developed a
number of draft recommendations for consideration by the NVAC. The NVAC
draft report details the background and rationale for each of these
recommendations and provides input on how the ASH might support HHS
activities in these areas. The draft report and draft recommendations
from the working group will inform NVAC deliberations as the NVAC
finalizes their recommendations for transmittal to the ASH.
NVPO is soliciting public comment on the draft report and draft
recommendations from a variety of stakeholders, including the general
public, for consideration by the NVAC as they develop their final
recommendations to the ASH. It is anticipated that the draft report and
draft recommendations, as revised with consideration given to public
comment and stakeholder input, will be presented to the NVAC for
adoption in June 2014 at the quarterly NVAC meeting.
DATES: Comments for consideration by the NVAC should be received no
later than 5:00 p.m. EDT on April 25, 2014.
ADDRESSES:
(1) The draft report and draft recommendations are available on the
web at https://www.hhs.gov/nvpo/nvac/.
(2) Electronic responses are preferred and may be addressed to:
Jennifer.Gordon@hhs.gov.
(3) Written responses should be addressed to: National Vaccine
Program Office, U.S. Department of Health and Human Services, 200
Independence Avenue SW., Room 733G, Washington, DC 20201. Attn: HHS
Maternal Immunizations c/o Dr. Jennifer Gordon
FOR FURTHER INFORMATION CONTACT: Jennifer Gordon, Ph.D., National
Vaccine Program Office, Office of the Assistant Secretary for Health,
Department of Health and Human Services; telephone (202) 260-6619; fax
(202) 260-1165; email: Jennifer.Gordon@hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
Pregnant women and their infants are at increased risk for serious
complications due to vaccine-preventable diseases. For example, during
the 2009 H1N1 influenza pandemic, pregnant women accounted for five
percent of all reported H1N1-related deaths and were 7.2 times more
[[Page 16798]]
likely to be hospitalized than non-pregnant women. Infants too young to
be vaccinated are also vulnerable to severe outcomes and death due to
influenza and pertussis disease. Maternal immunization is an important
strategy to protect both pregnant women and their young infants from
vaccine-preventable disease, and both the Advisory Committee for
Immunization Practices and the American College of Obstetricians and
Gynecologists recommend that all pregnant women receive immunizations
against influenza and pertussis disease during every pregnancy.
However, despite evidence to support clear health benefits of maternal
immunization for pregnant women and infant, immunization coverage in
pregnant women remains low. In addition, many pregnant women reported
that their provider did not recommend that they receive vaccines,
indicating ongoing missed opportunities during healthcare interactions.
Therefore, it is critical to understand the barriers that both prevent
pregnant women from receiving recommended vaccinations and those that
prevent obstetrical care providers from recommending and administering
vaccines within their practices. Doing so will help to advance maternal
immunization efforts and increase coverage to maximize the number of
pregnant women and young infants that can benefit from these
strategies.
Through their analysis and discussion, the NVAC identified five
major areas of opportunity:
1. Enhancing communication to address the safety and effectiveness
of all currently recommended immunizations during pregnancy;
2. Maximizing obstetric provider recommendation and administration
of recommended maternal immunizations;
3. Focusing efforts to improve financing for immunization services
during pregnancy and postpartum;
4. Supporting efforts to increase the use of electronic health
records (EHRs) and Immunization Information Systems (IISs) among
obstetrical care providers; and
5. Recognizing and addressing current vaccine liability law
barriers to optimize investigations and uptake of recommended and
future vaccines during pregnancy.
Within each area the NVAC report details key recommendations to
overcoming challenges in these areas.
II. Request for Comment
NVPO, on behalf of the NVAC Maternal Immunizations Working Group,
requests input on the draft report and draft recommendations. In
addition to general comments on the draft report and draft
recommendations, NVPO is seeking input on efforts or barriers to
maternal immunizations not represented in the report where HHS efforts
could advance maternal immunization efforts. Please limit your comments
to six (6) pages.
III. Potential Responders
HHS invites input from a broad range of stakeholders including
individuals and organizations that have interests in maternal
immunization efforts and the role of HHS in advancing those efforts.
Examples of potential responders include, but are not limited to,
the following:
--general public;
--advocacy groups, non-profit organizations, and public interest
organizations;
--academics, professional societies, and healthcare organizations;
--public health officials and immunization program managers;
--obstetrical care provider groups including all physician and non-
physician providers that administer healthcare services to pregnant
women, including pharmacists; and
--representatives from the private sector.
When responding, please self-identify with any of the above or
other categories (include all that apply) and your name. Anonymous
submissions will not be considered. Written submissions should not
exceed six (6) pages. Please do not send proprietary, commercial,
financial, business, confidential, trade secret, or personal
information.
Dated: March 13, 2014.
Bruce Gellin,
Deputy Assistant Secretary for Health, Director, National Vaccine
Program Office, Executive Secretary, National Vaccine Advisory
Committee.
[FR Doc. 2014-06594 Filed 3-25-14; 8:45 am]
BILLING CODE 4150-44-P
